Mary Nauffal, PharmD, MS, BCOP, discusses innovative use of isatuximab for red cell aplasia post stem cell transplant, highlighting its potential in clinical trials.
Mary Nauffal, PharmD, MS, BCOP
Advertisement
Articles by Mary Nauffal, PharmD, MS, BCOP
Advertisement
Latest Updated Articles
Expert: Isatuximab Demonstrates Potential in Treating Immune Cytopenias After Stem Cell TransplantPublished: September 29th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Bacteria and Fungi in the Mouth Found to Drive Pancreatic Cancer Risk
2
Pfizer Agrees to Lower Certain Drug Prices in US, Aligning With ‘Most-Favored Nation’ Plan
3
Op-Ed: Why Pharmacy Benefits Need a New Approach
4
Expert: Pharmacists Guide the Future of Gene Therapy in Oncology and Hematology
5
